Share Price and Basic Stock Data
Last Updated: October 10, 2025, 11:02 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Rajshree Sugars & Chemicals Ltd, operating in the sugar industry, currently trades at ₹40.1 with a market capitalization of ₹133 Cr. The company’s core business revolves around sugar production and chemical manufacturing. Analyzing the quarterly and annual sales trends, the data indicates a consistent revenue stream, with minor fluctuations. Operating profit margins (OPM) have shown a negative trend at -4%, which could be attributed to various factors impacting the industry, such as fluctuating sugar prices and input costs. It is essential to closely monitor these trends to understand the company’s financial health and market dynamics.
Profitability and Efficiency Metrics
Examining profitability and efficiency metrics, the company’s Return on Equity (ROE) stands at 3.05%, while Return on Capital Employed (ROCE) is at 4.42%. The Net Profit reported is ₹8, reflecting a modest performance. With an Interest Coverage Ratio (ICR) of 0.60x, the company faces challenges in meeting its interest obligations. The Cash Conversion Cycle (CCC) of 34 days indicates the efficiency of the company in managing its working capital. These metrics suggest that Rajshree Sugars & Chemicals Ltd may need to focus on improving its profitability and operational efficiency to enhance shareholder value.
Balance Sheet Strength and Financial Ratios
The company’s reserves amount to ₹231 Cr, while borrowings stand at ₹299 Cr, reflecting a higher reliance on debt financing. The Price-to-Book Value (P/BV) ratio is at 0.65x, indicating that the stock may be undervalued concerning its book value. However, the Interest Coverage Ratio (ICR) of 0.60x raises concerns about the company’s ability to service its debt obligations. Monitoring debt-equity ratios and liquidity positions will be crucial in assessing the company’s financial health and stability.
Shareholding Pattern and Investor Confidence
Analyzing the shareholding pattern, promoters hold a significant stake of 40.71%, while Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) have smaller stakes of 0.14% and 2.88%, respectively. Public shareholding stands at 56.26%, reflecting a diverse investor base. Changes in promoter holdings and institutional participation can influence market perception and stock valuations. Understanding investor confidence through shareholding patterns is vital for evaluating the company’s credibility and potential growth prospects.
Outlook, Risks, and Final Insight
Looking ahead, key growth drivers for Rajshree Sugars & Chemicals Ltd could include expanding product lines, increasing operational efficiency, and tapping into new markets. However, risks such as volatile commodity prices, regulatory challenges, and economic uncertainties could pose threats to the company’s future performance. Strengthening financial stability, improving profitability ratios, and enhancing investor confidence will be critical for navigating these challenges. In conclusion, while the company shows potential for growth, mitigating risks and maintaining a robust financial position will be crucial for long-term sustainability and value creation for stakeholders.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Rajshree Sugars & Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gayatri Sugars Ltd | 112 Cr. | 15.1 | 21.4/7.02 | 699 | 11.4 | 0.00 % | 36.6 % | % | 10.0 |
| Dhampure Speciality Sugars Ltd | 74.8 Cr. | 89.8 | 142/84.0 | 24.2 | 41.0 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
| Dhampur Bio Organics Ltd | 546 Cr. | 82.2 | 154/57.3 | 152 | 1.52 % | 3.97 % | 1.56 % | 10.0 | |
| DCM Shriram Industries Ltd | 1,496 Cr. | 172 | 214/142 | 17.2 | 103 | 1.17 % | 13.7 % | 11.8 % | 2.00 |
| Davangere Sugar Company Ltd | 548 Cr. | 3.83 | 13.2/3.03 | 48.5 | 2.39 | 0.00 % | 6.80 % | 3.22 % | 1.00 |
| Industry Average | 1,849.14 Cr | 273.72 | 54.42 | 229.21 | 0.62% | 8.62% | 7.89% | 6.37 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 225 | 185 | 139 | 218 | 228 | 213 | 137 | 186 | 240 | 146 | 81 | 175 | 141 |
| Expenses | 226 | 179 | 152 | 158 | 210 | 185 | 155 | 158 | 224 | 135 | 98 | 146 | 146 |
| Operating Profit | -1 | 6 | -13 | 60 | 18 | 28 | -18 | 28 | 16 | 11 | -17 | 29 | -5 |
| OPM % | -0% | 3% | -10% | 28% | 8% | 13% | -13% | 15% | 7% | 7% | -21% | 17% | -4% |
| Other Income | 0 | 2 | 3 | 2 | 1 | 1 | 0 | 11 | 0 | 4 | 6 | 1 | 0 |
| Interest | 5 | 2 | 4 | 3 | 4 | 5 | 4 | 10 | 5 | -2 | 4 | 9 | 3 |
| Depreciation | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Profit before tax | -11 | 0 | -21 | 53 | 9 | 17 | -28 | 23 | 6 | 11 | -20 | 15 | -14 |
| Tax % | 0% | 0% | 0% | 56% | 0% | 0% | 0% | 32% | 0% | 0% | 0% | 20% | 0% |
| Net Profit | -11 | 0 | -21 | 23 | 9 | 17 | -28 | 16 | 6 | 11 | -20 | 12 | -14 |
| EPS in Rs | -3.44 | 0.07 | -6.39 | 7.06 | 2.57 | 5.18 | -8.37 | 4.77 | 1.79 | 3.24 | -6.17 | 3.58 | -4.27 |
Last Updated: August 20, 2025, 4:45 am
Below is a detailed analysis of the quarterly data for Rajshree Sugars & Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 141.00 Cr.. The value appears to be declining and may need further review. It has decreased from 175.00 Cr. (Mar 2025) to 141.00 Cr., marking a decrease of 34.00 Cr..
- For Expenses, as of Jun 2025, the value is 146.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 146.00 Cr..
- For Operating Profit, as of Jun 2025, the value is -5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Mar 2025) to -5.00 Cr., marking a decrease of 34.00 Cr..
- For OPM %, as of Jun 2025, the value is -4.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Mar 2025) to -4.00%, marking a decrease of 21.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 6.00 Cr..
- For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to -14.00 Cr., marking a decrease of 29.00 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 20.00% (Mar 2025) to 0.00%, marking a decrease of 20.00%.
- For Net Profit, as of Jun 2025, the value is -14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to -14.00 Cr., marking a decrease of 26.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -4.27. The value appears to be declining and may need further review. It has decreased from 3.58 (Mar 2025) to -4.27, marking a decrease of 7.85.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:12 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 830 | 574 | 570 | 667 | 552 | 399 | 327 | 364 | 468 | 767 | 764 | 642 | 543 |
| Expenses | 766 | 566 | 532 | 526 | 518 | 385 | 319 | 336 | 436 | 715 | 708 | 603 | 525 |
| Operating Profit | 64 | 9 | 38 | 141 | 34 | 14 | 9 | 28 | 32 | 52 | 56 | 39 | 17 |
| OPM % | 8% | 1% | 7% | 21% | 6% | 4% | 3% | 8% | 7% | 7% | 7% | 6% | 3% |
| Other Income | 6 | 10 | 32 | 3 | 24 | 3 | 3 | 10 | 12 | 7 | 13 | 12 | 12 |
| Interest | 73 | 65 | 65 | 72 | 60 | 58 | 58 | 29 | 22 | 14 | 24 | 16 | 14 |
| Depreciation | 35 | 30 | 26 | 26 | 25 | 25 | 25 | 24 | 24 | 24 | 24 | 23 | 24 |
| Profit before tax | -39 | -76 | -21 | 46 | -27 | -65 | -70 | -16 | -3 | 21 | 21 | 11 | -9 |
| Tax % | -31% | -31% | -31% | 34% | -54% | -36% | -30% | 6% | 22% | 143% | 35% | 27% | |
| Net Profit | -27 | -53 | -14 | 30 | -13 | -42 | -49 | -17 | -3 | -9 | 14 | 8 | -12 |
| EPS in Rs | -11.21 | -22.18 | -5.74 | 10.67 | -4.47 | -14.85 | -17.52 | -5.95 | -0.96 | -2.71 | 4.15 | 2.44 | -3.62 |
| Dividend Payout % | 0% | 0% | 0% | 9% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -96.30% | 73.58% | 314.29% | -143.33% | -223.08% | -16.67% | 65.31% | 82.35% | -200.00% | 255.56% | -42.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | 169.88% | 240.70% | -457.62% | -79.74% | 206.41% | 81.97% | 17.05% | -282.35% | 455.56% | -298.41% |
Rajshree Sugars & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 14% |
| 3 Years: | 11% |
| TTM: | -30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 17% |
| 3 Years: | 55% |
| TTM: | -207% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 26% |
| 3 Years: | 8% |
| 1 Year: | -40% |
| Return on Equity | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | -1% |
| 3 Years: | 1% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 12:55 pm
Balance Sheet
Last Updated: July 25, 2025, 2:29 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 25 | 28 | 28 | 28 | 28 | 28 | 33 | 33 | 33 | 33 |
| Reserves | 81 | 24 | 12 | 116 | 103 | 62 | 11 | 2 | 228 | 218 | 232 | 231 |
| Borrowings | 654 | 675 | 691 | 615 | 458 | 403 | 358 | 432 | 427 | 401 | 393 | 299 |
| Other Liabilities | 270 | 145 | 145 | 330 | 170 | 250 | 283 | 213 | 249 | 170 | 148 | 123 |
| Total Liabilities | 1,029 | 867 | 873 | 1,089 | 760 | 743 | 680 | 676 | 938 | 822 | 806 | 687 |
| Fixed Assets | 544 | 513 | 489 | 551 | 528 | 505 | 483 | 427 | 612 | 589 | 569 | 524 |
| CWIP | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 1 | 1 |
| Investments | 55 | 67 | 67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 427 | 285 | 315 | 537 | 230 | 236 | 196 | 248 | 325 | 232 | 236 | 161 |
| Total Assets | 1,029 | 867 | 873 | 1,089 | 760 | 743 | 680 | 676 | 938 | 822 | 806 | 687 |
Below is a detailed analysis of the balance sheet data for Rajshree Sugars & Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 33.00 Cr..
- For Reserves, as of Mar 2025, the value is 231.00 Cr.. The value appears to be declining and may need further review. It has decreased from 232.00 Cr. (Mar 2024) to 231.00 Cr., marking a decrease of 1.00 Cr..
- For Borrowings, as of Mar 2025, the value is 299.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 393.00 Cr. (Mar 2024) to 299.00 Cr., marking a decrease of 94.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 123.00 Cr.. The value appears to be improving (decreasing). It has decreased from 148.00 Cr. (Mar 2024) to 123.00 Cr., marking a decrease of 25.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 687.00 Cr.. The value appears to be improving (decreasing). It has decreased from 806.00 Cr. (Mar 2024) to 687.00 Cr., marking a decrease of 119.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 524.00 Cr.. The value appears to be declining and may need further review. It has decreased from 569.00 Cr. (Mar 2024) to 524.00 Cr., marking a decrease of 45.00 Cr..
- For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 161.00 Cr.. The value appears to be declining and may need further review. It has decreased from 236.00 Cr. (Mar 2024) to 161.00 Cr., marking a decrease of 75.00 Cr..
- For Total Assets, as of Mar 2025, the value is 687.00 Cr.. The value appears to be declining and may need further review. It has decreased from 806.00 Cr. (Mar 2024) to 687.00 Cr., marking a decrease of 119.00 Cr..
However, the Borrowings (299.00 Cr.) are higher than the Reserves (231.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -590.00 | -666.00 | -653.00 | -474.00 | -424.00 | -389.00 | -349.00 | -404.00 | -395.00 | -349.00 | -337.00 | -260.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 14 | 22 | 35 | 31 | 31 | 57 | 48 | 31 | 24 | 19 | 15 | 14 |
| Inventory Days | 145 | 160 | 192 | 285 | 129 | 144 | 109 | 175 | 196 | 96 | 113 | 90 |
| Days Payable | 88 | 93 | 92 | 157 | 118 | 218 | 222 | 208 | 180 | 87 | 78 | 70 |
| Cash Conversion Cycle | 71 | 89 | 135 | 159 | 42 | -17 | -64 | -1 | 40 | 27 | 50 | 34 |
| Working Capital Days | -26 | -41 | -66 | -65 | -89 | -227 | -414 | -63 | -16 | 7 | -6 | 3 |
| ROCE % | 5% | -2% | 2% | 16% | 2% | -1% | -3% | 2% | 3% | 5% | 7% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 9.42 | 10.56 | -5.98 | -27.61 | -14.44 |
| Diluted EPS (Rs.) | 9.42 | 10.56 | -5.09 | -27.61 | -14.44 |
| Cash EPS (Rs.) | 18.40 | 19.74 | 3.50 | -14.23 | 1.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 46.73 | 37.20 | -0.69 | 5.99 | 35.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 46.73 | 37.20 | -0.69 | 5.99 | 35.39 |
| Revenue From Operations / Share (Rs.) | 196.07 | 236.66 | 285.49 | 298.69 | 388.12 |
| PBDIT / Share (Rs.) | 12.89 | 51.13 | 17.62 | 3.86 | 28.34 |
| PBIT / Share (Rs.) | 3.91 | 41.85 | 6.39 | -9.52 | 12.18 |
| PBT / Share (Rs.) | -17.42 | 16.28 | -11.19 | -39.83 | -20.90 |
| Net Profit / Share (Rs.) | 9.42 | 10.46 | -7.73 | -27.61 | -14.44 |
| NP After MI And SOA / Share (Rs.) | 9.42 | 10.46 | -7.73 | -27.61 | -14.44 |
| PBDIT Margin (%) | 6.57 | 21.60 | 6.17 | 1.29 | 7.30 |
| PBIT Margin (%) | 1.99 | 17.68 | 2.23 | -3.18 | 3.13 |
| PBT Margin (%) | -8.88 | 6.88 | -3.91 | -13.33 | -5.38 |
| Net Profit Margin (%) | 4.80 | 4.42 | -2.70 | -9.24 | -3.72 |
| NP After MI And SOA Margin (%) | 4.80 | 4.42 | -2.70 | -9.24 | -3.72 |
| Return on Networth / Equity (%) | 20.15 | 28.12 | 0.00 | -460.75 | -40.80 |
| Return on Capital Employeed (%) | 2.64 | 25.45 | 3.62 | -4.55 | 4.58 |
| Return On Assets (%) | 3.49 | 2.64 | -2.05 | -6.85 | -3.08 |
| Long Term Debt / Equity (X) | 2.16 | 3.36 | -258.45 | 33.96 | 6.17 |
| Total Debt / Equity (X) | 2.79 | 4.73 | -374.08 | 46.25 | 8.16 |
| Asset Turnover Ratio (%) | 0.58 | 0.65 | 0.62 | 0.57 | 0.79 |
| Current Ratio (X) | 0.61 | 0.84 | 0.73 | 0.78 | 1.00 |
| Quick Ratio (X) | 0.20 | 0.36 | 0.18 | 0.16 | 0.32 |
| Inventory Turnover Ratio (X) | 1.05 | 1.61 | 1.72 | 1.50 | 2.36 |
| Interest Coverage Ratio (X) | 0.60 | 2.00 | 0.61 | 0.12 | 0.85 |
| Interest Coverage Ratio (Post Tax) (X) | 0.42 | 1.42 | 0.34 | 0.08 | 0.56 |
| Enterprise Value (Cr.) | 451.53 | 614.15 | 745.71 | 699.22 | 658.60 |
| EV / Net Operating Revenue (X) | 0.81 | 0.92 | 1.05 | 0.98 | 0.71 |
| EV / EBITDA (X) | 12.43 | 4.26 | 16.95 | 76.15 | 9.77 |
| MarketCap / Net Operating Revenue (X) | 0.15 | 0.26 | 0.13 | 0.06 | 0.06 |
| Price / BV (X) | 0.65 | 1.67 | -55.23 | 3.18 | 0.74 |
| Price / Net Operating Revenue (X) | 0.15 | 0.26 | 0.13 | 0.06 | 0.06 |
| EarningsYield | 0.30 | 0.16 | -0.20 | -1.45 | -0.54 |
After reviewing the key financial ratios for Rajshree Sugars & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 18, the value is 9.42. This value is within the healthy range. It has decreased from 10.56 (Mar 17) to 9.42, marking a decrease of 1.14.
- For Diluted EPS (Rs.), as of Mar 18, the value is 9.42. This value is within the healthy range. It has decreased from 10.56 (Mar 17) to 9.42, marking a decrease of 1.14.
- For Cash EPS (Rs.), as of Mar 18, the value is 18.40. This value is within the healthy range. It has decreased from 19.74 (Mar 17) to 18.40, marking a decrease of 1.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 46.73. It has increased from 37.20 (Mar 17) to 46.73, marking an increase of 9.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 46.73. It has increased from 37.20 (Mar 17) to 46.73, marking an increase of 9.53.
- For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 196.07. It has decreased from 236.66 (Mar 17) to 196.07, marking a decrease of 40.59.
- For PBDIT / Share (Rs.), as of Mar 18, the value is 12.89. This value is within the healthy range. It has decreased from 51.13 (Mar 17) to 12.89, marking a decrease of 38.24.
- For PBIT / Share (Rs.), as of Mar 18, the value is 3.91. This value is within the healthy range. It has decreased from 41.85 (Mar 17) to 3.91, marking a decrease of 37.94.
- For PBT / Share (Rs.), as of Mar 18, the value is -17.42. This value is below the healthy minimum of 0. It has decreased from 16.28 (Mar 17) to -17.42, marking a decrease of 33.70.
- For Net Profit / Share (Rs.), as of Mar 18, the value is 9.42. This value is within the healthy range. It has decreased from 10.46 (Mar 17) to 9.42, marking a decrease of 1.04.
- For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is 9.42. This value is within the healthy range. It has decreased from 10.46 (Mar 17) to 9.42, marking a decrease of 1.04.
- For PBDIT Margin (%), as of Mar 18, the value is 6.57. This value is below the healthy minimum of 10. It has decreased from 21.60 (Mar 17) to 6.57, marking a decrease of 15.03.
- For PBIT Margin (%), as of Mar 18, the value is 1.99. This value is below the healthy minimum of 10. It has decreased from 17.68 (Mar 17) to 1.99, marking a decrease of 15.69.
- For PBT Margin (%), as of Mar 18, the value is -8.88. This value is below the healthy minimum of 10. It has decreased from 6.88 (Mar 17) to -8.88, marking a decrease of 15.76.
- For Net Profit Margin (%), as of Mar 18, the value is 4.80. This value is below the healthy minimum of 5. It has increased from 4.42 (Mar 17) to 4.80, marking an increase of 0.38.
- For NP After MI And SOA Margin (%), as of Mar 18, the value is 4.80. This value is below the healthy minimum of 8. It has increased from 4.42 (Mar 17) to 4.80, marking an increase of 0.38.
- For Return on Networth / Equity (%), as of Mar 18, the value is 20.15. This value is within the healthy range. It has decreased from 28.12 (Mar 17) to 20.15, marking a decrease of 7.97.
- For Return on Capital Employeed (%), as of Mar 18, the value is 2.64. This value is below the healthy minimum of 10. It has decreased from 25.45 (Mar 17) to 2.64, marking a decrease of 22.81.
- For Return On Assets (%), as of Mar 18, the value is 3.49. This value is below the healthy minimum of 5. It has increased from 2.64 (Mar 17) to 3.49, marking an increase of 0.85.
- For Long Term Debt / Equity (X), as of Mar 18, the value is 2.16. This value exceeds the healthy maximum of 1. It has decreased from 3.36 (Mar 17) to 2.16, marking a decrease of 1.20.
- For Total Debt / Equity (X), as of Mar 18, the value is 2.79. This value exceeds the healthy maximum of 1. It has decreased from 4.73 (Mar 17) to 2.79, marking a decrease of 1.94.
- For Asset Turnover Ratio (%), as of Mar 18, the value is 0.58. It has decreased from 0.65 (Mar 17) to 0.58, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 18, the value is 0.61. This value is below the healthy minimum of 1.5. It has decreased from 0.84 (Mar 17) to 0.61, marking a decrease of 0.23.
- For Quick Ratio (X), as of Mar 18, the value is 0.20. This value is below the healthy minimum of 1. It has decreased from 0.36 (Mar 17) to 0.20, marking a decrease of 0.16.
- For Inventory Turnover Ratio (X), as of Mar 18, the value is 1.05. This value is below the healthy minimum of 4. It has decreased from 1.61 (Mar 17) to 1.05, marking a decrease of 0.56.
- For Interest Coverage Ratio (X), as of Mar 18, the value is 0.60. This value is below the healthy minimum of 3. It has decreased from 2.00 (Mar 17) to 0.60, marking a decrease of 1.40.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 0.42. This value is below the healthy minimum of 3. It has decreased from 1.42 (Mar 17) to 0.42, marking a decrease of 1.00.
- For Enterprise Value (Cr.), as of Mar 18, the value is 451.53. It has decreased from 614.15 (Mar 17) to 451.53, marking a decrease of 162.62.
- For EV / Net Operating Revenue (X), as of Mar 18, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 17) to 0.81, marking a decrease of 0.11.
- For EV / EBITDA (X), as of Mar 18, the value is 12.43. This value is within the healthy range. It has increased from 4.26 (Mar 17) to 12.43, marking an increase of 8.17.
- For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 17) to 0.15, marking a decrease of 0.11.
- For Price / BV (X), as of Mar 18, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 1.67 (Mar 17) to 0.65, marking a decrease of 1.02.
- For Price / Net Operating Revenue (X), as of Mar 18, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 17) to 0.15, marking a decrease of 0.11.
- For EarningsYield, as of Mar 18, the value is 0.30. This value is below the healthy minimum of 5. It has increased from 0.16 (Mar 17) to 0.30, marking an increase of 0.14.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Rajshree Sugars & Chemicals Ltd:
- Net Profit Margin: 4.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.64% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.15% (Industry Average ROE: 7.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.42
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.2
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 54.42)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.79
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | The Uffizi, Coimbatore Tamil Nadu 641004 | investor@rajshreesugars.com http://www.rajshreesugars.com |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Rajshree Pathy | Chairperson |
| Mr. R Varadarajan | Whole Time Director |
| Mr. K Ilango | Independent Director |
| Mr. Sheilendra Bhansali | Independent Director |
| Mr. S Vasudevan | Independent Director |
| Mr. S Krishnaswami | Independent Director |
FAQ
What is the intrinsic value of Rajshree Sugars & Chemicals Ltd?
Rajshree Sugars & Chemicals Ltd's intrinsic value (as of 10 October 2025) is 29.75 which is 23.52% lower the current market price of 38.90, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹127 Cr. market cap, FY2025-2026 high/low of 72.3/32.7, reserves of ₹231 Cr, and liabilities of 687 Cr.
What is the Market Cap of Rajshree Sugars & Chemicals Ltd?
The Market Cap of Rajshree Sugars & Chemicals Ltd is 127 Cr..
What is the current Stock Price of Rajshree Sugars & Chemicals Ltd as on 10 October 2025?
The current stock price of Rajshree Sugars & Chemicals Ltd as on 10 October 2025 is 38.9.
What is the High / Low of Rajshree Sugars & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Rajshree Sugars & Chemicals Ltd stocks is 72.3/32.7.
What is the Stock P/E of Rajshree Sugars & Chemicals Ltd?
The Stock P/E of Rajshree Sugars & Chemicals Ltd is .
What is the Book Value of Rajshree Sugars & Chemicals Ltd?
The Book Value of Rajshree Sugars & Chemicals Ltd is 79.7.
What is the Dividend Yield of Rajshree Sugars & Chemicals Ltd?
The Dividend Yield of Rajshree Sugars & Chemicals Ltd is 0.00 %.
What is the ROCE of Rajshree Sugars & Chemicals Ltd?
The ROCE of Rajshree Sugars & Chemicals Ltd is 4.42 %.
What is the ROE of Rajshree Sugars & Chemicals Ltd?
The ROE of Rajshree Sugars & Chemicals Ltd is 3.05 %.
What is the Face Value of Rajshree Sugars & Chemicals Ltd?
The Face Value of Rajshree Sugars & Chemicals Ltd is 10.0.